StockData
InnovAge Holding Corp. logo

InnovAge Holding Corp. (INNV) stock

INNVNasdaqServices-Health ServicesFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 11/3066% above fair value
$9.42−0.16 (-1.67%)

Close on Nov 17, 2026Market cap $1.29BP/E –Yield –

Earnings

InnovAge's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 2, 2027
Q2 FY2027 · estimated, during market hours
Revenue, Q1 FY2027
$264.80M
+12.2% on a year earlier
EPS, Q1 FY2027
$0.14
$0.06 a year earlier
Latest guidance
Raised
Nov 3, 2026 · 4 items

Quarterly results

Revenue and earnings per share from each of InnovAge's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q2 FY2027ended Dec 31, 2026Feb 2, 2027Expected––––
Q1 FY2027ended Sep 30, 2026Nov 3, 2026after the close$264.80M+12.2%$0.14Release
Q4 FY2026ended Jun 30, 2026Sep 8, 2026during market hours$261.95M+18.3%$0.06Release
Q3 FY2026ended Mar 31, 2026May 5, 2026during market hours$251.90M+15.5%-$0.22Release
Q2 FY2026ended Dec 31, 2025Feb 3, 2026during market hours$239.70M+14.7%$0.08Release
Q1 FY2026ended Sep 30, 2025Nov 4, 2025during market hours$236.10M+15.1%$0.06Release
Q4 FY2025ended Jun 30, 2025Sep 9, 2025during market hours$221.42M+11.0%-$0.01Release
Q3 FY2025ended Mar 31, 2025May 6, 2025during market hours$218.14M+13.0%-$0.08Release
Q2 FY2025ended Dec 31, 2024Feb 4, 2025during market hours$209.00M+10.6%-$0.10Release
Q1 FY2025ended Sep 30, 2024Nov 5, 2024during market hours$205.10M+12.4%-$0.04Release
Q4 FY2024ended Jun 30, 2024Sep 10, 2024during market hours$199.40M+12.7%-$0.01Release
Q3 FY2024ended Mar 31, 2024May 7, 2024during market hours$193.10M+11.9%-$0.04Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

InnovAge's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
Total revenuesGAAPFY2027$1.05B – $1.09B–NewNov 3, 2026
Total revenuesFY2027$1.05B – $1.09B–NewSep 8, 2026
Adjusted EBITDAnon-GAAPFY2027$105.00M – $115.00M–NewNov 3, 2026
Adjusted EBITDAnon-GAAPFY2027$105.00M – $115.00M–NewSep 8, 2026
CensusFY20278625 – 8850–NewNov 3, 2026
CensusFY20278625 – 8850–NewSep 8, 2026
Total Member MonthsFY2027101,000 – 102,500–RaisedNov 3, 2026
Total Member MonthsFY2027101,000 – 102,500–RaisedSep 8, 2026

Guidance vs results

The last range InnovAge gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
FY2026Revenue$950.00M – $975.00M$989.65MΣ4QAbove range
FY2025Revenue$815.00M – $865.00M$853.66MΣ4QWithin range

Guidance history

Every forecast InnovAge put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 3, 2026Adjusted EBITDAFY2027$105.00M – $115.00MNew
Nov 3, 2026CensusFY20278625 – 8850New
Nov 3, 2026Total Member MonthsFY2027101,000 – 102,500Raised
Nov 3, 2026Total revenuesFY2027$1.05B – $1.09BNew
Sep 8, 2026Adjusted EBITDAFY2027$105.00M – $115.00MNew
Sep 8, 2026CensusFY20278625 – 8850New
Sep 8, 2026Total Member MonthsFY2027101,000 – 102,500Raised
Sep 8, 2026Total revenuesFY2027$1.05B – $1.09BNew
May 5, 2026Adjusted EBITDAFY2026$85.00M – $90.00MRaised
May 5, 2026CensusFY20267900 – 8100Lowered
May 5, 2026Total Member MonthsFY202692,900 – 95,700Raised
May 5, 2026Total revenuesFY2026$950.00M – $975.00MNew
Feb 3, 2026Adjusted EBITDAFY2026$70.00M – $75.00MRaised
Feb 3, 2026CensusFY20267900 – 8100Lowered
Feb 3, 2026Total Member MonthsFY202692,900 – 95,700Raised
Feb 3, 2026Total revenuesFY2026$925.00M – $950.00MRaised
Nov 4, 2025Adjusted EBITDAFY2026$56.00M – $65.00MReaffirmed
Nov 4, 2025CensusFY20267900 – 8100Lowered
Nov 4, 2025Total Member MonthsFY202691,600 – 94,400Raised
Nov 4, 2025Total revenuesFY2026$900.00M – $950.00MReaffirmed

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases InnovAge filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Update
  4. Results
  5. Results
  6. Update
  7. Update
  8. Results
  9. Results
  10. Results
  11. Results
  12. Results
  13. Update
  14. News
  15. Results

See a number that looks wrong?